To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

Zai Lab released Phase 1a data Thursday morning as it attempts to compete with a recently approved Amgen drug. The program, ...

A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy — similar to ...

Under the terms of the license agreement, Monopar will pay Alexion an upfront in the form of a cash payment and equity in Monopar. Future payments are based on tiered royalties on net sales and ...

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

According to Morgan Stanley, the global market for blockbuster obesity drugs could increase by more than 15x over the next five years, as their benefits expand beyond weight loss, with expected ...

In the latest UPC update, we review the NanoString and iMop rulings, a big move in London and a decision on whether a patent ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

Novo Nordisk and Eli Lilly still have first-mover advantage, but Roche, Pfizer and others all have similar products in the ...

A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy -; similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory ...

In a report released today, Christopher Raymond from Piper Sandler maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research ...